Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARGX argenex	$543.32 -0.3%	$575.98	$432.96 ▼ $678.21	$33.18B	0.37	329,756 shs	289,592 shs
CAH Cardinal Health	$164.80 +1.7%	$155.58	$93.17 ▼ $168.44	$39.37B	0.68	2.25 million shs	1.23 million shs
HOLX Hologic	$64.74 -0.9%	$60.71	$51.90 ▼ $84.67	$14.44B	0.55	2.37 million shs	1.23 million shs
PHG Koninklijke Philips	$24.17 -1.4%	$23.71	$20.61 ▼ $31.57	$23.27B	0.76	899,654 shs	871,452 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARGX argenex	0.00%	-3.00%	-5.26%	-2.12%	+24.82%
CAH Cardinal Health	0.00%	-1.43%	+6.88%	+27.39%	+72.20%
HOLX Hologic	0.00%	-0.42%	+3.46%	+6.37%	-11.90%
PHG Koninklijke Philips	0.00%	+0.12%	+5.13%	+9.45%	-7.09%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARGX argenex	4.3077 of 5 stars	4.5	3.0	0.0	0.0	2.4	1.7	2.5
CAH Cardinal Health	4.823 of 5 stars	2.4	4.0	4.2	3.6	3.5	1.7	1.9
HOLX Hologic	4.8239 of 5 stars	3.2	4.0	0.0	4.3	2.9	3.3	1.9
PHG Koninklijke Philips	3.6907 of 5 stars	0.0	5.0	1.7	0.0	2.7	0.0	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARGX argenex	3.05	Buy	$728.06	34.00% Upside
CAH Cardinal Health	2.79	Moderate Buy	$157.43	-4.47% Downside
HOLX Hologic	2.41	Hold	$77.42	19.59% Upside
PHG Koninklijke Philips	3.00	Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest HOLX, PHG, ARGX, and CAH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/3/2025	ARGX argenex	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$700.00
7/1/2025	ARGX argenex	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$720.00
6/24/2025	ARGX argenex	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$715.00
6/13/2025	CAH Cardinal Health	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$166.00 ➝ $181.00
6/13/2025	CAH Cardinal Health	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$157.00 ➝ $170.00
6/12/2025	CAH Cardinal Health	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$175.00 ➝ $180.00
6/11/2025	ARGX argenex	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$715.00
6/10/2025	ARGX argenex	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$720.00
6/10/2025	CAH Cardinal Health	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$165.00 ➝ $170.00
6/3/2025	CAH Cardinal Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$136.00 ➝ $179.00
5/27/2025	HOLX Hologic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARGX argenex	$2.25B	14.73	$2.97 per share	182.96	$90.49 per share	6.00
CAH Cardinal Health	$226.83B	0.17	$10.53 per share	15.65	($13.19) per share	-12.49
HOLX Hologic	$4.03B	3.58	$5.50 per share	11.78	$22.09 per share	2.93
PHG Koninklijke Philips	$19.50B	1.19	$3.10 per share	7.80	$13.86 per share	1.74

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARGX argenex	$833.04M	$16.21	33.52	50.08	0.98	40.20%	16.15%	14.33%	7/24/2025 (Estimated)
CAH Cardinal Health	$852M	$6.41	25.71	18.41	1.63	0.70%	-68.84%	4.21%	8/13/2025 (Estimated)
HOLX Hologic	$789.50M	$2.37	27.31	14.01	2.37	13.83%	19.71%	10.87%	7/30/2025 (Estimated)
PHG Koninklijke Philips	-$758.55M	$0.43	56.21	12.52	0.68	2.11%	10.97%	4.57%	7/29/2025 (Estimated)

Latest HOLX, PHG, ARGX, and CAH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q3 2025	HOLX Hologic	$1.05	N/A	N/A	N/A	$1.01 billion	N/A
7/29/2025	Q2 2025	PHG Koninklijke Philips	$0.2907	N/A	N/A	N/A	$4.35 billion	N/A
7/24/2025	Q2 2025	ARGX argenex	$2.87	N/A	N/A	N/A	$776.82 million	N/A
5/8/2025	Q1 2025	ARGX argenex	$2.32	$2.58	+$0.26	$2.58	$748.34 million	$1.35 billion
5/6/2025	Q1 2025	PHG Koninklijke Philips	$0.14	$0.27	+$0.13	$0.09	$4.10 billion	$4.31 billion
5/1/2025	Q3 2025	CAH Cardinal Health	$2.15	$2.35	+$0.20	$2.10	$55.33 billion	$54.88 billion
5/1/2025	Q2 2025	HOLX Hologic	$1.02	$1.03	+$0.01	-$0.08	$1.00 billion	$1.01 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARGX argenex	N/A	N/A	N/A	N/A	N/A
CAH Cardinal Health	$2.04	1.24%	N/A	31.83%	29 Years
HOLX Hologic	N/A	N/A	N/A	N/A	N/A
PHG Koninklijke Philips	$0.82	3.39%	N/A	190.70%	N/A

Latest HOLX, PHG, ARGX, and CAH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/5/2025	CAH Cardinal Health	quarterly	$0.5107	1.35%	7/1/2025	7/1/2025	7/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARGX argenex	N/A	7.29	6.68
CAH Cardinal Health	N/A	0.94	0.50
HOLX Hologic	0.54	3.24	2.52
PHG Koninklijke Philips	0.60	1.28	0.79

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARGX argenex	60.32%
CAH Cardinal Health	87.17%
HOLX Hologic	94.73%
PHG Koninklijke Philips	13.67%

Insider Ownership

Company	Insider Ownership
ARGX argenex	2.43%
CAH Cardinal Health	0.09%
HOLX Hologic	1.88%
PHG Koninklijke Philips	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARGX argenex	1,599	61.06 million	59.58 million	Optionable
CAH Cardinal Health	48,900	238.68 million	238.46 million	Optionable
HOLX Hologic	7,063	222.85 million	218.66 million	Optionable
PHG Koninklijke Philips	66,678	962.92 million	N/A	Optionable

HOLX, PHG, ARGX, and CAH Headlines

Recent News About These Companies

Timber Creek Capital Management LLC Buys 88,012 Shares of Koninklijke Philips N.V. (NYSE:PHG)

July 4 at 8:28 AM | marketbeat.com

Aurora Private Wealth Inc. Takes $1.70 Million Position in Koninklijke Philips N.V. (NYSE:PHG)

July 4 at 6:35 AM | marketbeat.com

We gave the 'beautiful' Philips Hue Go table lamp a glowing review – and it's just dropped to a record-low price

July 3 at 7:34 PM | techradar.comT

What tariffs? Philips Hue lights get early Prime Day discounts

July 3 at 7:34 PM | msn.com

Philips wins FDA clearance for AI MRI software SmartSpeed Precise

July 2 at 1:14 PM | massdevice.com

Philips, Medtronic re-up patient monitoring partnership

July 1, 2025 | fiercebiotech.comF

Koninklijke Philips N.V. (NYSE:PHG) Shares Sold by Envestnet Portfolio Solutions Inc.

July 1, 2025 | marketbeat.com

EOFY Sale 2025: Save $251 on Philips 5000 Series XXL Air Fryer

June 30, 2025 | news.com.auN

Philips, Medtronic expand patient monitoring collaboration

June 30, 2025 | massdevice.com

PHG Koninklijke Philips N.V. - Seeking Alpha

June 27, 2025 | seekingalpha.com

Perpetual Ltd Has $21.61 Million Holdings in Koninklijke Philips N.V. (NYSE:PHG)

June 27, 2025 | marketbeat.com

Philips Hue Prices Set to Rise Beginning July 1 Due to Impending Tariffs

June 26, 2025 | techtimes.comT

Philips Hue lighting is getting even more expensive on July 1 as a ‘direct result’ of tariffs

June 26, 2025 | 9to5google.com9

Philips Hue smart lights are already pricey. They’re about to get pricier

June 26, 2025 | msn.com

Philips Evnia 27M2N3501PA Review: Affordable QHD 240Hz Gaming Monitor

June 26, 2025 | guru3d.comG

You've got one week to stock up on Philips Hue gear before a tariff-fueled price hike

June 26, 2025 | androidauthority.comA

Philips Hue says US prices will go up in July because of tariffs

June 26, 2025 | msn.com

Philips Hue bulbs will be even more expensive in July. And it may not end there.

June 26, 2025 | arstechnica.comA

Global Assets Advisory LLC Acquires New Shares in Koninklijke Philips N.V. (NYSE:PHG)

June 26, 2025 | marketbeat.com

Methodist Hospitals Selects Philips to Advance Neurovascular, Cardiology and Complex Interventional Radiology Services in Northwest Indiana

June 25, 2025 | businesswire.com

Philips’ Dr Carla Goulart Peron on AI, equity and the future of care

June 25, 2025 | emjreviews.comE

New MarketBeat Followers Over Time

Media Sentiment Over Time

HOLX, PHG, ARGX, and CAH Company Descriptions

argenex NASDAQ:ARGX

$543.32 -1.79 (-0.33%)

As of 07/3/2025 01:43 PM Eastern

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

Cardinal Health NYSE:CAH

$164.80 +2.82 (+1.74%)

Closing price 07/3/2025 03:41 PM Eastern

Extended Trading

$164.80 0.00 (0.00%)

As of 07/3/2025 04:53 PM Eastern

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Hologic NASDAQ:HOLX

$64.74 -0.57 (-0.87%)

As of 07/3/2025 03:46 PM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Koninklijke Philips NYSE:PHG

$24.17 -0.35 (-1.43%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$24.18 +0.00 (+0.02%)

As of 07/3/2025 04:54 PM Eastern

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time